Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lorch

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
World Journal of Urology|December 17, 2025
Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patientsStefan Sponholz, Georgios Karaindros, Kyriaki Chalepaki Ntelli, et al.
The Oncologist|February 12, 2020
Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 PatientsJosias Grogg, Kym Schneider, Peter Karl Bode, et al.
Urologic Oncology|December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study GroupChristoph Seidel, Karin Oechsle, Anja Lorch, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2020
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series dataJosias Bastian Grogg, Kym Schneider, Peter-Karl Bode, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Oncoimmunology|May 4, 2018
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius, Madeleine C Killer, Nina Timmesfeld, et al.
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2021
Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series dataJosias Bastian Grogg, Jordi Nicola Fronzaroli, Pedro Oliveira, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care centerTamara Rordorf, Panagiotis Balermpas, Tomas Brezina, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2014
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)Lars Arne Berger, Carsten Bokemeyer, Anja Lorch, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
World Journal of Urology|December 17, 2025
Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patientsStefan Sponholz, Georgios Karaindros, Kyriaki Chalepaki Ntelli, et al.
The Oncologist|February 12, 2020
Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 PatientsJosias Grogg, Kym Schneider, Peter Karl Bode, et al.
Urologic Oncology|December 25, 2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study GroupChristoph Seidel, Karin Oechsle, Anja Lorch, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2020
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series dataJosias Bastian Grogg, Kym Schneider, Peter-Karl Bode, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Oncoimmunology|May 4, 2018
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius, Madeleine C Killer, Nina Timmesfeld, et al.
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2021
Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series dataJosias Bastian Grogg, Jordi Nicola Fronzaroli, Pedro Oliveira, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care centerTamara Rordorf, Panagiotis Balermpas, Tomas Brezina, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2014
First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)Lars Arne Berger, Carsten Bokemeyer, Anja Lorch, et al.
Pageof 8